Comment on Estrogen plus progestin and breast cancer incidence and mortality in the Women's Health Initiative Observational Study. [J Natl Cancer Inst. 2013
Previous studies had shown that there is little concern about endometrial cancer risk with hormone r...
Epidemiological and biological data on HRT and breast cancer risk are reviewed. Some aspects deserve...
Breast cancer is the commonest cancer among women in the western world, accounting for up to 30% of ...
Comment on Estrogen plus progestin and breast cancer incidence and mortality in the Women's Health I...
Several studies on hormone replacement therapy (HRT) in the USA have been published. They revealed t...
concludes that a combination of estro-gen and progestin increases the risk of breast cancer over tim...
Background In the Women's Health Initiative (WHI) randomized trial, estrogen plus progestin increase...
Estrogen plus progestin increased long-term risk for invasive breast cancer in postmenopausal women ...
Three large clinical trials provoked major debate when hormone replacement therapy (HRT) did not red...
The authors conducted a prospective cohort analysis in the Women’s Health Study (1992–2004), a compl...
TheWomen’s Health Initiative trial found a modestly increased risk of invasive breast cancer with da...
Epidemiological studies have shown an increased risk of breast cancer associated with the use of hor...
Publication of the Women’s Health Initiative trial of post-menopausal hormone therapy caused re-thin...
Grace Mariko Kalish, Elizabeth Barrett-Connor, Gail A. Laughlin, Barbara I. Gulanski, Association of...
Ross et al. (1) report that women us-ing estrogen and progestin, compared with nonusers, have a 10 %...
Previous studies had shown that there is little concern about endometrial cancer risk with hormone r...
Epidemiological and biological data on HRT and breast cancer risk are reviewed. Some aspects deserve...
Breast cancer is the commonest cancer among women in the western world, accounting for up to 30% of ...
Comment on Estrogen plus progestin and breast cancer incidence and mortality in the Women's Health I...
Several studies on hormone replacement therapy (HRT) in the USA have been published. They revealed t...
concludes that a combination of estro-gen and progestin increases the risk of breast cancer over tim...
Background In the Women's Health Initiative (WHI) randomized trial, estrogen plus progestin increase...
Estrogen plus progestin increased long-term risk for invasive breast cancer in postmenopausal women ...
Three large clinical trials provoked major debate when hormone replacement therapy (HRT) did not red...
The authors conducted a prospective cohort analysis in the Women’s Health Study (1992–2004), a compl...
TheWomen’s Health Initiative trial found a modestly increased risk of invasive breast cancer with da...
Epidemiological studies have shown an increased risk of breast cancer associated with the use of hor...
Publication of the Women’s Health Initiative trial of post-menopausal hormone therapy caused re-thin...
Grace Mariko Kalish, Elizabeth Barrett-Connor, Gail A. Laughlin, Barbara I. Gulanski, Association of...
Ross et al. (1) report that women us-ing estrogen and progestin, compared with nonusers, have a 10 %...
Previous studies had shown that there is little concern about endometrial cancer risk with hormone r...
Epidemiological and biological data on HRT and breast cancer risk are reviewed. Some aspects deserve...
Breast cancer is the commonest cancer among women in the western world, accounting for up to 30% of ...
DOI
Add to ORKG